Unprecedented levels of antimicrobial resistance in bacterial isolates have prompted great
concerns globally. In 2012 the WHO released a publication outlining the evolving threat of …

The role of tigecycline in treating multidrug-resistant Acinetobacter baumannii (MDR-AB)
infections remains controversial. A systematic review and meta-analysis was performed to …

BACKGROUND: β-Lactam antibiotics demonstrate time-dependent killing. Prolonged
infusion of these agents is commonly performed to optimize the time the unbound …

The lack of active antimicrobial agents against multidrug-resistant (MDR) Acinetobacter
baumannii has posed great threat to the public health. Combination therapies with …

Carbapenem-resistant Acinetobacter baumannii (CRAB) is an important clinical threat.
Combination therapy that exerts a synergistic effect has become a potential solution to …

Objective Acinetobacter baumannii is one of the most important pathogenic bacteria causing
nosocomial infections and has a high mortality rate. Assessment of the microbiological …

Acinetobacter (inmóvil) es un cocobacilo Gram (-) que durante las tres últimas décadas,
emerge desde un organismo de patogenicidad cuestionable a un agente infeccioso …

Background Tigecycline has in vitro bacteriostatic activity against a broad spectrum of
bacteria, including carbapenem-resistant Gram-negative bacteria (CR-GNB). However, the …

Cefoperazone/sulbactam has been shown to be efficacious for the treatment of infections
caused by Acinetobacter baumannii; however, the mechanism underlying resistance to this …

Introduction An online survey was conducted to characterize current infection management
practices in Italian intensive care units (ICUs), including the antibacterial and antifungal drug …